Veterans Integrated Service Network 19 established a Blanket Purchase Agreement with Biomerieux Inc. on September 30, 2026, against the GSA In Vitro Diagnostics, Reagents, Test Schedule (FSS-65-VII), with a ceiling of $6.379 million and an ultimate completion date of September 29, 2027.
The BPA procures BioFire reagents and maintenance services for TORCH diagnostic systems across six VA Medical Centers within VISN 19: Cheyenne, Eastern Oklahoma (Muskogee), Grand Junction, James E. Inhofe, Salt Lake City, and Sheridan. The award was made as a sole-source procurement under FAR 15.7104-3, restricted to Biomerieux due to proprietary system constraints—only BioFire reagents are compatible with the government-owned BioFire TORCH analyzers, and only BioFire/Biomerieux certified technicians may perform maintenance.
A BPA call was issued on September 30, 2026, for $491,015.38 covering biofire reagents and maintenance services supporting TORCH systems in Salt Lake City, with firm fixed-price pricing and completion by September 29, 2027. NAICS code 325413 (In-Vitro Diagnostic Substance Manufacturing) applies with a business size standard of 1,250 employees.